Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study-Reference-Cited by-同舟云学术

Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study

Published:2020-03 Issue: Volume:17 Page:100499
ISSN:2451-8654
Container-title:Contemporary Clinical Trials Communications
language:en
Short-container-title:Contemporary Clinical Trials Communications

Author:

Kapoor Mahendra Parkash,Suzuki Koji,Derek Timm,Ozeki Makoto,Okubo Tsutomu

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference33 articles.

1. The global epidemic of the metabolic syndrome;Saklayen;Curr. Hypertens. Rep.,2018

2. Reversibility of endothelial dysfunction in diabetes: role of polyphenols;Suganya;Br. J. Nutr.,2016

3. Endothelial dysfunction;Vanhoutte;Circ. J.,2009

4. Current trends in the research of Emblica officinalis (Amla): a pharmacological perspective;Dasaroju;Int. J. Pharm. Sci. Rev. Res.,2014

5. Emblica officinalis (Amla): a review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms;Variya;Pharmacol. Res.,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional effects and mechanisms of Phyllanthus emblica fruit and gallic acid on metabolic diseases: Experimental evidence and clinical perspectives;Food Bioscience;2024-06

2. The effect of an oral product containing Amla fruit (Phyllanthus emblica L.) on female androgenetic alopecia: A randomized controlled trial;Journal of Ethnopharmacology;2024-01

3. Medicinal Plants, Secondary Metabolites, and Their Antiallergic Activities;Biotechnology of Medicinal Plants with Antiallergy Properties;2024

4. Promising remedies for cardiovascular disease: Natural polyphenol ellagic acid and its metabolite urolithins;Phytomedicine;2023-07

5. Clinical effects of Emblica officinalis fruit consumption on cardiovascular disease risk factors: a systematic review and meta-analysis;BMC Complementary Medicine and Therapies;2023-06-09